All News

As a cancer survivor, please know you are not alone and for your own sake as well as theirs, reach out to fellow survivors.

Although still in early phases, an oncolytic virus, called DNX-2401, may be a groundbreaking therapy in pediatric patients with diffuse intrinsic pontine gliomas.

In the time you take to make an excuse, you could have the self-exam done.

CURE spoke with a childhood development specialist and colorectal cancer survivor to offer firsthand advice and tips on how to discuss a cancer diagnosis with children of any age.

Mother's Day is a special time for remembering our mothers, and even when breast cancer was involved, the memories can still be sweet.

Believe me, if I thought a baking soda solution would cure my cancer, I’d be first in line. It’s cheap and it won’t make my hair fall out, make me vomit or send my white blood count spiraling down.

It is tough to cope with a cancer diagnosis, and I want to give a sincere, but belated, thank you to my oncologists and oncology nurses.

If you've ever thought about clinical trials for your care, different resources may make that decision easier.

Use these five easy conversation starters to be on the ball with the men in your life!

During National Women’s Lung Health Week, a lung cancer survivor shares her story and success with targeted therapy.

During the fourth annual Virginia Vines event, the V Foundation helped raise funds for cancer research and provided education on recent advancements in the treatment landscape.

In our lives before cancer, we have several avenues for our energy including family, work, school, volunteer work and on and on. We were able to juggle it all. But after a diagnosis, we need to choose one or two passions and let the rest go.

The photographers’ excitement to be involved led to a number of photo sessions for “fighter families” as Dawson calls them. After just a few sessions, it was apparent the Gold Hope Project was a hit.

As a double mastectomy with reconstruction patient, I made the stupid decision to try to wean off pain medication only two weeks after cancer surgery.

Inspired by a text message with a close friend, I'm starting a research study to answer this. I need your help.

The Food and Drug Administration (FDA) granted approval to Darzalex (daratumumab) in combination with Velcade (bortezomib), melphalan and prednisone – also known as VMP – for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant (ASCT).

The chemoWave app, launched in July 2017, is designed to manage cancer symptoms and conditions by keeping track of a patient’s overall well-being.

A higher complete response rate was seen in patients given both agents compared with those given Imbruvica alone.

Survivors teach medical and nursing students around the world about early disease signs and symptoms.

How a young boy on chemo marked the days until the end of his treatments.

The FDA has granted a priority review to a supplemental biologics license application (sBLA) for Tecentriq (atezolizumab) to be used in combination with Avastin (bevacizumab), carboplatin and paclitaxel for the first-line treatment of patients with metastatic nonsquamous non–small cell lung cancer (NSCLC).

The treatment landscape of mantle cell lymphoma is continuing to change. See what expert Andre Goy, M.D., has to say about it.

Keeping a healthy weight is vital for everyone, especially breast cancer survivors.

A guy with breast cancer reveals a secret that can save your life.

A look back on that time more than 200 men grabbed their balls in public.

The Food and Drug Administration (FDA) approved the two-drug combination Tafinlar (dabrafenib) and Mekinist (trametinib) to treat patients with metastatic or unresectable anaplastic thyroid cancer (ATC), whose tumors harbor the BRAF V600E mutation.

I think being an athlete is what saved my life.

Immunotherapy is making landmark change in the treatment of patients with genitourinary (GU) cancers, with bladder cancer being the pioneer in the field, having five FDA-approved checkpoint inhibitors. But kidney cancer is not far behind, with a breakthrough therapy designation granted for a Keytruda (pembrolizumab) combination this past January.